IDEXX Announces CEO Succession

Core Viewpoint - IDEXX Laboratories, Inc. has announced the promotion of Michael (Mike) Erickson, PhD, to President and CEO effective May 12, 2026, as part of a planned succession process, with Jonathan (Jay) Mazelsky transitioning to Executive Chair of the Board [1][3] Group 1: Leadership Transition - Dr. Erickson has nearly two decades of leadership experience and has held senior positions at IDEXX since 2011, currently serving as Executive Vice President and General Manager of Global Point of Care Diagnostics and Telemedicine [2] - The Board's decision to appoint Dr. Erickson is based on a robust succession planning process, recognizing his deep understanding of the business and suitability to lead IDEXX forward [3] - Mr. Mazelsky will retire following the annual meeting of shareholders in May 2027 and will assist Dr. Erickson during the transition period [1][3] Group 2: Company Overview - IDEXX Laboratories is a global leader in pet healthcare innovation, providing diagnostic and software products that enhance veterinary medicine [4] - The company employs approximately 11,000 people and offers solutions in over 175 countries, contributing to the health and well-being of pets, people, and livestock [4]